Cancer Regulatory Pathways and Immune Activity

Cancer Regulatory Pathways and Immune Activity

Understanding cancer biology at pathway and immune level

ATLUS Targeting, combined with long-read RNA sequencing, enables a deeper understanding of cancer regulatory pathways and immune activity by capturing full-length transcripts with high resolution.

This reveals how gene regulation, signalling pathways, and immune responses are shaped at the isoform level, providing insights often missed by conventional approaches.

What It Enables

Pathway-Level Insight

Precise characterisation of regulatory networks, including transcription factors, signalling pathways, and isoform-driven variation.

Immune Profiling

Detailed analysis of immune-related transcripts, including cytokines, receptors, and checkpoint isoforms associated with activation or evasion.

Integrated Understanding

Linking pathway alterations with immune dynamics to uncover mechanisms of progression, response, and resistance.

Why It Matters

Cancer progression and treatment response are driven by complex interactions between regulatory pathways and the immune system.

ATLUS Targeting enables a more complete, systems-level view, supporting the discovery of immuno-oncology targets, predictive biomarkers, and more effective therapies.